Surrozen, Inc. (SRZN)
19.96
-0.72
(-3.48%)
USD |
NASDAQ |
Sep 09, 16:00
19.96
0.00 (0.00%)
After-Hours: 17:10
Surrozen Total Liabilities (Quarterly) : 334.27M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 334.27M |
| March 31, 2026 | 398.86M |
| December 31, 2025 | 286.49M |
| September 30, 2025 | 117.56M |
| June 30, 2025 | 55.58M |
| March 31, 2025 | 109.16M |
| December 31, 2024 | 69.85M |
| September 30, 2024 | 42.33M |
| June 30, 2024 | 39.01M |
| March 31, 2024 | 6.58M |
| December 31, 2023 | 8.145M |
| September 30, 2023 | 8.442M |
| Date | Value |
|---|---|
| June 30, 2023 | 8.941M |
| March 31, 2023 | 11.16M |
| December 31, 2022 | 13.43M |
| September 30, 2022 | 13.94M |
| June 30, 2022 | 14.43M |
| March 31, 2022 | 14.99M |
| December 31, 2021 | 27.47M |
| September 30, 2021 | 26.90M |
| June 30, 2021 | 9.903M |
| March 31, 2021 | 6.808M |
| December 31, 2020 | 14.77M |
| September 30, 2020 | 0.0306M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.61M |
| Shareholders Equity (Quarterly) | -218.66M |
| Debt to Equity Ratio | -0.0289 |
| Current Ratio | 12.14 |
| Net Debt Paydown Yield | 0.11% |